Related Experiment Video
Updated: May 3, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Excipient lung disease with transient severe pulmonary hypertension in a healthcare professional injecting crushed
Matthew T Donnan1, Catriona McLean2, Miranda Siemienowicz3,4
1Department of Respiratory Medicine, Alfred Health, Melbourne, Victoria, Australia.
Abstract:
Excipient lung disease (ELD) is a rare cause of pulmonary hypertension that occurs due to the intravenous injection of crushed tablets. We present the case of a healthcare professional in her late 30s who presented with a fever in the setting of a Stenotrophomonas maltophilia bacteraemia. During her hospital admission, she established a pattern of transient hypoxia and hypotension, with resolution without targeted management or clear cause identified. She developed progressive pulmonary centrilobular micronodularity on computed tomography and severe pre-capillary pulmonary hypertension. Lung biopsy revealed pulmonary arteriolar deposition of microcrystalline cellulose with an associated giant cell reaction leading to the diagnosis of ELD secondary to injection of crushed oxycodone tablets. In the setting of abstinence from intravenous drug use, the patient made a full recovery. ELD is rare and requires a high index of suspicion to diagnose. Treatment is largely supportive and should include removal of excipient exposure and addiction medicine services.
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pneumothorax-II
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

